IRIS
MASSIRONI, SARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.699
AS - Asia 3.358
EU - Europa 3.215
SA - Sud America 704
Continente sconosciuto - Info sul continente non disponibili 269
AF - Africa 62
OC - Oceania 3
Totale 11.310
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.466
RU - Federazione Russa 1.871
SG - Singapore 1.118
CN - Cina 910
IT - Italia 677
BR - Brasile 540
HK - Hong Kong 479
VN - Vietnam 332
BD - Bangladesh 240
FR - Francia 177
DE - Germania 107
GB - Regno Unito 101
CA - Canada 82
IN - India 62
MX - Messico 61
AR - Argentina 54
NL - Olanda 41
SE - Svezia 40
AT - Austria 36
ES - Italia 34
FI - Finlandia 33
PL - Polonia 33
CO - Colombia 32
ID - Indonesia 31
TR - Turchia 31
ZA - Sudafrica 23
JP - Giappone 22
IQ - Iraq 20
CR - Costa Rica 19
EC - Ecuador 19
JM - Giamaica 17
VE - Venezuela 16
CL - Cile 12
MY - Malesia 12
PH - Filippine 12
SA - Arabia Saudita 12
HN - Honduras 11
PK - Pakistan 11
UY - Uruguay 10
MA - Marocco 9
PY - Paraguay 9
LT - Lituania 8
MD - Moldavia 8
NI - Nicaragua 8
TN - Tunisia 8
AE - Emirati Arabi Uniti 7
IE - Irlanda 7
TT - Trinidad e Tobago 7
UA - Ucraina 7
DZ - Algeria 6
NP - Nepal 6
UZ - Uzbekistan 6
BO - Bolivia 5
CZ - Repubblica Ceca 5
GT - Guatemala 5
JO - Giordania 5
PE - Perù 5
PT - Portogallo 5
TW - Taiwan 5
BB - Barbados 4
CY - Cipro 4
OM - Oman 4
BE - Belgio 3
BH - Bahrain 3
BN - Brunei Darussalam 3
BS - Bahamas 3
CH - Svizzera 3
DO - Repubblica Dominicana 3
EG - Egitto 3
GR - Grecia 3
IL - Israele 3
KE - Kenya 3
KZ - Kazakistan 3
SV - El Salvador 3
AL - Albania 2
AU - Australia 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
EE - Estonia 2
ET - Etiopia 2
GD - Grenada 2
KR - Corea 2
KW - Kuwait 2
LB - Libano 2
PA - Panama 2
PR - Porto Rico 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
TH - Thailandia 2
AM - Armenia 1
AO - Angola 1
BZ - Belize 1
DK - Danimarca 1
GE - Georgia 1
GF - Guiana Francese 1
HR - Croazia 1
IR - Iran 1
KH - Cambogia 1
KN - Saint Kitts e Nevis 1
Totale 11.025
Salva come PNG Salva come JPEG
Città #
Singapore 584
San Jose 547
Hong Kong 467
Dallas 460
Moscow 393
Ashburn 380
Council Bluffs 222
Hefei 160
Milan 158
Beijing 145
Lauterbourg 136
New York 124
Phoenix 112
Ho Chi Minh City 111
Shanghai 90
Santa Clara 89
Hanoi 77
Los Angeles 77
São Paulo 58
Rome 48
Orem 41
Nuremberg 33
Mexico City 31
Naples 31
Montreal 30
Warsaw 29
Atlanta 28
Buffalo 28
Turin 26
Brooklyn 25
Chicago 24
Houston 21
London 21
Tokyo 20
Da Nang 19
San Diego 19
Munich 18
Rio de Janeiro 18
Frankfurt am Main 17
Amsterdam 16
San Francisco 16
Bologna 15
Brescia 15
Charlotte 15
Figino 15
Haiphong 15
Helsinki 15
Vienna 15
Bari 14
Denver 14
Las Vegas 14
Omaha 14
Poplar 14
San José 14
Stockholm 14
Toronto 14
Chennai 13
Genoa 13
Ankara 12
Boardman 12
Brasília 12
Falkenstein 12
Johannesburg 12
Memphis 12
Seattle 12
Curitiba 11
Lappeenranta 11
Mumbai 11
Queens 11
The Bronx 11
Detroit 10
Manchester 10
Miami 10
Palermo 10
Philadelphia 10
Catania 9
Guangzhou 9
Quito 9
Thái Bình 9
Assago 8
Boston 8
Columbus 8
Hải Dương 8
Kingston 8
Lawrence 8
Baghdad 7
Belo Horizonte 7
Bogotá 7
Dhaka 7
Managua 7
Ribeirão Preto 7
Santiago 7
St Louis 7
Stezzano 7
Tianjin 7
Turku 7
Barnet 6
Caracas 6
Chengdu 6
Cleveland 6
Totale 5.566
Salva come PNG Salva come JPEG
Nome #
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 205
Diagnosis and treatment of nutritional deficiencies in alcoholic liver disease : overview of available evidence and open issues 172
Association of Upfront Peptide Receptor Radionuclide Therapy With Progression-Free Survival Among Patients With Enteropancreatic Neuroendocrine Tumors 169
Autoimmune pancreatitis: Cornerstones and future perspectives 158
Any role for transarterial radioembolization in unresectable intrahepatic cholangiocarcinoma in the era of advanced systemic therapies? 150
Inflammation and malnutrition in inflammatory bowel disease 135
Venous Thromboembolism in Patients with Neuroendocrine Neoplasms: A Systematic Review of Incidence, Types, and Clinical Outcomes 124
Micronutrient deficiencies in patients with chronic atrophic autoimmune gastritis: A review 124
The Endoscopic Management of Anastomotic Strictures After Esophagogastric Surgery: A Comprehensive Review of Emerging Approaches Beyond Endoscopic Dilation 120
Clinical and biological heterogeneity of Grade 2 digestive neuroendocrine neoplasms: prognostic significance of the 10% Ki-67 index cutoff and implications for treatment strategies. A longitudinal study 114
Management of Asymptomatic Sporadic Nonfunctioning Pancreatic Neuroendocrine Neoplasms (ASPEN) ≤2 cm: Study Protocol for a Prospective Observational Study 112
Italian Chronic Pancreatitis Registry (ITARECIPE): Protocol for a nationwide cohort study 109
Immunity in digestive diseases: new drugs for inflammatory bowel disease treatment—insights from Phase II and III trials 108
Endoscopic Submucosal Dissection (ESD) for the Management of Fibrotic Non-Lifting Colorectal Lesions (NLCLs): Results from a Large Multicenter Retrospective Study 107
Advances in Endo-Hepatology: The Role of Endoscopic Ultrasound in the Management of Portal Hypertension 106
The Role of Vitamin D in Inflammatory Bowel Diseases: From Deficiency to Targeted Therapeutics and Precise Nutrition Strategies 104
Clinical Outcome of Patients with Gastric, Duodenal, or Rectal Neuroendocrine Tumors after Incomplete Endoscopic Resection 104
Beyond the gluten-free diet: Innovations in celiac disease therapeutics 101
Epidemiology of gastroenteropancreatic neuroendocrine neoplasms: a review and protocol presentation for bridging tumor registry data with the Italian association for neuroendocrine tumors (Itanet) national database 99
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial 98
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis 96
Accuracy of Ultrasonography, Spiral CT, Magnetic Resonance, and Alpha-Fetoprotein in Diagnosing Hepatocellular Carcinoma: A Systematic Review: CME 92
Advancements in Barrett's esophagus detection: The role of artificial intelligence and its implications 91
Assessment of the Risk of Nodal Involvement in Rectal Neuroendocrine Neoplasms: The NOVARA Score, a Multicentre Retrospective Study 89
Any Role for Microbiota in Cholangiocarcinoma? A Comprehensive Review 88
Duodenal Gastric Metaplasia and Duodenal Neuroendocrine Neoplasms: More Than a Simple Coincidence? 88
Duodenal neuroendocrine neoplasms: a still poorly recognized clinical entity 88
Autoimmune gastritis: an organ-specific disease or a model of systemic autoimmunity? Parallels, divergences, and emerging insights 86
ASO Author Reflections: Heterogeneity of Duodenal Neuroendocrine Tumors. 86
An esophageal gastrointestinal stromal tumor in a patient with MEN1-related pancreatic gastrinoma : an unusual association and review of the literature 85
Ultrasound muscle assessment for sarcopenia detection in inflammatory bowel disease: A prospective study 85
The Role of Therapeutic Endoscopic Ultrasound in Management of Malignant Double Obstruction (Biliary and Gastric Outlet): A Comprehensive Review with Clinical Scenarios 84
Paradoxical association between dyspepsia and autoimmune chronic atrophic gastritis: Insights into mechanisms, pathophysiology, and treatment options 84
Acute mesenteric ischemia and small bowel imaging findings in COVID-19: A comprehensive review of the literature 84
Nutritional aspects in neuroendocrine neoplasms. bridging the gap between dietary interventions and cancer care strategies: a scoping review 83
Incidence and prevalence of gastric neuroendocrine tumors in patients with chronic atrophic autoimmune gastritis 83
Unraveling the Microbiome's Role in Neuroendocrine Neoplasms: A New Perspective 83
Occurrence and characteristics of endoscopic gastric polyps in patients with autoimmune gastritis (AGAPE study): A multicentric cross-sectional study 82
"Pseudotumoral” hepatic pattern in acute alcoholic hepatitis : a case report 82
Transforming Gastrointestinal Diagnosis with Molecular Endoscopy: Challenges and Opportunities 81
A classification prognostic score to predict OS in stage IV well-differentiated neuroendocrine tumors 80
Autoimmune Pancreatitis Mimicking a Pancreatic Neuroendocrine Tumor: A Case Report with a Literature Review 79
Nonconventional Doses of Somatostatin Analogs in Patients With Progressing Well-Differentiated Neuroendocrine Tumor 79
A wait-and-watch approach to small pancreatic neuroendocrine tumors : Prognosis and survival 79
Second primary neoplasms in patients with lung and gastroenteropancreatic neuroendocrine neoplasms: Data from a retrospective multi-centric study 78
Advancing transmural remission as a treatment target in Crohn's disease: The future of tight-control strategy? 78
Endoscopic ultrasound appearance of pancreatic serotonin-staining neuroendocrine neoplasms 75
Italian Association of Clinical Endocrinologists (AME) and Italian AACE Chapter Position Statement for Clinical Practice: Assessment of Response to Treatment and Follow-Up in Gastroenteropancreatic Neuroendocrine Neoplasms 75
"Pseudotumoral" hepatic areas in acute alcoholic hepatitis: A computed tomography and histological study 74
Biochemical Markers for Neuroendocrine Tumors: Traditional Circulating Markers and Recent Development—A Comprehensive Review 72
Plasma chromogranin A in patients with inflammatory bowel disease 72
An unusual endoscopic feature in the duodenum of a young girl with intraluminal duodenal diverticulum 72
Endoscopic Ultrasound Elastography in Pancreatic Diseases EUS-EG in Pancreatic Diseases 70
Gastro-entero-pancreatic neuroendocrine neoplasia: The rules for non-operative management 70
Endoscopic Resection for Duodenal Neuroendocrine Neoplasms between 10 and 20 mm—A Systematic Review and Meta-Analysis 67
Long-term albumin improves the outcomes of patients with decompensated cirrhosis and diabetes mellitus: Post hoc analysis of the ANSWER trial 67
High rates of 30-day mortality in patients with cirrhosis and COVID-19 67
A case of positive 68Ga-DOTATOC-PET/CT pancreatic heterotopia mimicking an intestinal neuroendocrine tumor 67
Chronic autoimmune atrophic gastritis associated with primary hyperparathyroidism: A transversal prospective study 65
Vasostatin-1: A novel circulating biomarker for ileal and pancreatic neuroendocrine neoplasms 65
Systematic review-Pancreatic involvement in inflammatory bowel disease 65
Chromogranin A in the Follow-up of Gastroenteropancreatic Neuroendocrine Neoplasms: Is It Really Game Over? A Systematic Review and Meta-analysis. 62
Management of asymptomatic sporadic non-functioning pancreatic neuroendocrine neoplasms no larger than 2 cm: interim analysis of prospective ASPEN trial 61
Chromogranin A in diagnosing and monitoring patients with gastro-entero-pancreatic neuroendocrine neoplasms : a large series from a single institution 60
CLINICAL AND ENDOSCOPIC-HISTOLOGICAL FEATURES OF MULTIFOCAL AND CORPUS-RESTRICTED ATROPHIC GASTRITIS PATIENTS WITH NONCARDIA GASTRIC CANCER OR DYSPLASIA: A MULTICENTER, CROSS-SECTIONAL STUDY 60
Gastrinoma and Zollinger Ellison syndrome: A roadmap for the management between new and old therapies 59
Understanding short bowel syndrome : current status and future perspectives 58
The changing face of chronic autoimmune atrophic gastritis: an updated comprehensive perspective 58
Small Bowel Ultrasound beyond Inflammatory Bowel Disease: An Updated Review of the Recent Literature 57
On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites 57
Gastric neuroendocrine neoplasms and proton pump inhibitors : fact or coincidence? 57
Gastric carcinoids : between underestimation and overtreatment 57
Hepatic pseudocystic metastasis of well-differentiated ileal neuroendocrine tumor : a case report with review of the literature 56
Clinical treatment of cholangiocarcinoma: an updated comprehensive review 56
Risk of preoperative understaging of duodenal neuroendocrine neoplasms: a plea for caution in the treatment strategy 56
COVID-19 in patients with neuroendocrine neoplasms: two-year results of the INTENSIVE study 55
Tumour type and size are prognostic factors in gastric neuroendocrine neoplasia: A multicentre retrospective study 55
Clinical challenge for gastroenterologists–Gastrointestinal manifestations of systemic mastocytosis: A comprehensive review 55
Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues 55
Primary sclerosing cholangitis associated with inflammatory bowel disease : An update 55
Nutritional deficiencies in inflammatory bowel disease : therapeutic approaches 55
Intermittent treatment of recurrent type-1 gastric carcinoids with somatostatin analogues in patients with chronic autoimmune atrophic gastritis 55
Somatostatin analogues in functioning gastroenteropancreatic neuroendocrine tumours : Literature review, clinical recommendations and schedules 54
New and Emerging Systemic Therapeutic Options for Advanced Cholangiocarcinoma 54
Should patients with IBS be submitted to painful rectal distention in clinical practice? [1] 54
Cell Blood Count Alterations and Patterns of Anaemia in Autoimmune Atrophic Gastritis at Diagnosis: A Multicentre Study 54
Heterogeneity of Duodenal Neuroendocrine Tumors: An Italian Multi-center Experience 54
Clinical impact of endoscopic ultrasonography on the management of neuroendocrine tumors: lights and shadows 54
Distinguishing features of autoimmune gastritis depending on previous H. pylori infection or positivity to anti-parietal cell antibodies: Results from the Autoimmune gastRitis Italian netwOrk Study grOup (ARIOSO) 53
Transient elastography assessment of the liver stiffness dynamics during acute hepatitis B 53
Effects of low-dose aspirin on clinical outcome and disease progression in patients with gastroenteropancreatic neuroendocrine neoplasm 53
Neuroendocrine tumors of the gastro-entero-pancreatic system 53
Neuroendocrine neoplasms of rectum: A management update 52
Therapeutic Challenges for Gastric Neuroendocrine Neoplasms: Take It or Leave It? 52
Endoscopic management of gastric, duodenal and rectal NETs: Position paper from the Italian Association for Neuroendocrine Tumors (Itanet), Italian Society of Gastroenterology (SIGE), Italian Society of Digestive Endoscopy (SIED) 52
Circulating ghrelin levels in patients with inflammatory bowel disease [1] 52
Morphological Factors Related to Nodal Metastases in Neuroendocrine Tumors of the Appendix: A Multicentric Retrospective Study 52
Endoscopic techniques for gastric neuroendocrine tumors: An update 52
Reply to: Correspondence on “High rates of 30-day mortality in patients with cirrhosis and COVID-19” 51
Gastrinoma and neurofibromatosis type 2: the first case report and review of the literature 51
Totale 7.904
Salva come PNG Salva come JPEG
Categoria #
all - tutte 49.384
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.384
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223 0 0 0 1 0 1 0 0 0 0 0 1
2022/202360 16 5 3 4 2 9 7 6 4 0 0 4
2023/202448 0 3 2 6 5 6 3 4 3 1 5 10
2024/20251.512 25 2 5 122 41 129 299 98 206 282 137 166
2025/20267.871 529 589 538 848 600 389 715 533 1.832 470 355 473
2026/20271.810 436 735 554 85 0 0 0 0 0 0 0 0
Totale 11.310